Brief: Ampio updates regulatory and clinical status for Ampion
07/11/2018 14:08
Nov 7 (Reuters) - Ampio Pharmaceuticals Inc AMPE.A :
* AMPIO UPDATES REGULATORY AND CLINICAL STATUS FOR AMPION
* AMPIO PHARMACEUTICALS INC - FDA HAS ACCEPTED A TYPE C
MEETING
PROPOSAL FROM AMPIO AND SCHEDULED MEETING BEFORE END OF NOV 2018
Source text for Eikon: ID:nPn4slssDa
Further company coverage: AMPE.A
((Briefs@thomsonreuters.com;))
Recent news on Ampio Pharmaceuticals
See all newsBrief: Ampio Announces Voluntary Delisting And SEC Deregistration
Brief: Ampio Provides Update On Results From Pre-IND Enabling Studies
Brief: Ampio Selects Ascendia Pharmaceuticals, Inc. To Provide CDMO Services To Support Clinical Development Of OA-201
Brief: Ampio Pharmaceuticals Announces Reverse Stock Split
Brief: Ampio Pharmaceuticals Inc - Holds Approximately $1.25 Million In A Deposit Account At Silicon Valley Bank